China Medical Technologies, Inc. to Announce Financial Results for the Second Quarter Ended September 30, 2007 on November 20, 2007

BEIJING, Oct. 22 /Xinhua-PRNewswire-FirstCall/ -- China Medical Technologies, Inc. (the “Company”) , a leading China-based medical device company that develops, manufactures and markets advanced in- vitro diagnostic products and high intensity focused ultrasound tumor therapy systems, today announced that it will report its unaudited financial results for the second quarter ended September 30, 2007 (“2Q FY2007") and will provide a revised range of targeted net revenues and non-GAAP adjusted net income for FY2007 after the U.S. market closes on November 20, 2007. The Company’s 2007 fiscal year ends on March 31, 2008. The Company’s management will host an earnings conference call at 8:00 p.m., Eastern Time on the same day of the earnings announcement (9:00 a.m. on November 21, 2007 Beijing/Hong Kong time).

A live webcast of the conference call will be available on http://ir.chinameditech.com .

A replay of this webcast will be available for one month on this website.

A telephone replay of the call will be available after the conclusion of the conference call through 10:00 p.m. Eastern Time on November 21, 2007. The dial-in details for the replay are as follows:

About China Medical Technologies, Inc.

China Medical Technologies is a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products using Enhanced Chemiluminescence (ECLIA) technology and Fluorescent in situ Hybridization (FISH) technology, to detect and monitor various diseases and disorders, and products using High Intensity Focused Ultrasound (HIFU) for the treatment of solid cancers and benign tumors. For more information, please visit http://www.chinameditech.com .

IR@chinameditech.com

CONTACT: Winnie Fan of China Medical Technologies, Inc., +86-10-6530-
8833, or IR@chinameditech.com

Web site: http://ir.chinameditech.com/
http://www.chinameditech.com/

MORE ON THIS TOPIC